PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots ...
Company launches multi-channel promotional campaign to drive market adoption U.S. losartan market totals $256M annually with 71M prescriptions, creating a significant opportunity for Arbli™ as the ...
As Russia’s assault in Ukraine intensifies, fear of radioactive fallout from accidental or intentional attacks on Ukraine’s nuclear plants, or from the use of a nuclear bomb, has triggered surging ...
Scienture launches Arbli, the first FDA-approved liquid losartan, expanding hypertension treatment access across US ...
Learn everything you need to know about Amoxicillin and Clavulanate Potassium-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side ...
Strides Pharma Science’s wholly owned subsidiary, Vensun Pharmaceuticals, Inc., USA and its partner Pharmaceutics International, Inc. (Pii) have received approval from the United States Food & Drug ...
HOLLYWOOD, Fla.--(BUSINESS WIRE)--Accu-Break Pharmaceuticals, Inc. (www.accubreak.com, “ABP”), a pharmaceutical company focused on the development and commercialization of innovative worldwide ...
The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians of the recall of Losartan potassium tablet by its manufacturers. Prof. Moji Adeyeye, the ...
Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback